» Articles » PMID: 8755564

A Novel Strategy for Generating Monoclonal Antibodies from Single, Isolated Lymphocytes Producing Antibodies of Defined Specificities

Overview
Specialty Science
Date 1996 Jul 23
PMID 8755564
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

We report a novel approach to the generation of monoclonal antibodies based on the molecular cloning and expression of immunoglobulin variable region cDNAs generated from single rabbit or murine lymphocytes that were selected for the production of specific antibodies. Single cells secreting antibodies for a specific peptide either from gp116 of the human cytomegalovirus or from gp120 of HIV-1 or for sheep red blood cells were selected using antigen-specific hemolytic plaque assays. Sheep red blood cells were coated with specific peptides in a procedure applicable to any antigen that can be biotinylated. Heavy- and light-chain variable region cDNAs were rescued from single cells by reverse transcription-PCR and expressed in the context of human immunoglobulin constant regions. These chimeric murine and rabbit monoclonal antibodies replicated the target specificities of the original antibody-forming cells. The selected lymphocyte antibody method exploits the in vivo mechanisms that generate high-affinity antibodies. This method can use lymphocytes from peripheral blood, can exploit a variety of procedures that identify individual lymphocytes producing a particular antibody, and is applicable to the generation of monoclonal antibodies from many species, including humans.

Citing Articles

Computational detection of antigen-specific B cell receptors following immunization.

Abbate M, Dupic T, Vigne E, Shahsavarian M, Walczak A, Mora T Proc Natl Acad Sci U S A. 2024; 121(35):e2401058121.

PMID: 39163333 PMC: 11363332. DOI: 10.1073/pnas.2401058121.


Immune interface interference vaccines: An evolution-informed approach to anti-bacterial vaccine design.

Croucher N Microb Biotechnol. 2024; 17(3):e14446.

PMID: 38536702 PMC: 10970203. DOI: 10.1111/1751-7915.14446.


Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies.

Singh R, Chandley P, Rohatgi S Immunohorizons. 2023; 7(12):886-897.

PMID: 38149884 PMC: 10759153. DOI: 10.4049/immunohorizons.2300102.


A Novel Rabbit Anti-Myoglobin Monoclonal Antibody's Potential Application in Rhabdomyolysis Associated Acute Kidney Injury.

Wang X, Qiao O, Han L, Li N, Gong Y Int J Mol Sci. 2023; 24(9).

PMID: 37175528 PMC: 10177957. DOI: 10.3390/ijms24097822.


Efficient isolation of rare B cells using next-generation antigen barcoding.

Hurtado J, Flynn C, Lee J, Salcedo E, Cottrell C, Skog P Front Cell Infect Microbiol. 2023; 12():962945.

PMID: 36968243 PMC: 10036767. DOI: 10.3389/fcimb.2022.962945.


References
1.
Konecny J, Eckert M, Schoniger M, Hofacker G . Neutral adaptation of the genetic code to double-strand coding. J Mol Evol. 1993; 36(5):407-16. DOI: 10.1007/BF02406718. View

2.
Ohlin M, Sundqvist V, Mach M, Wahren B, Borrebaeck C . Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. J Virol. 1993; 67(2):703-10. PMC: 237421. DOI: 10.1128/JVI.67.2.703-710.1993. View

3.
Friedman M, Tunyaplin C, Zhai S, Knight K . Neonatal VH, D, and JH gene usage in rabbit B lineage cells. J Immunol. 1994; 152(2):632-41. View

4.
Lonberg N, Taylor L, Harding F, Trounstine M, Higgins K, Schramm S . Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature. 1994; 368(6474):856-9. DOI: 10.1038/368856a0. View

5.
Griffiths A, Williams S, Hartley O, Tomlinson I, Waterhouse P, Crosby W . Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 1994; 13(14):3245-60. PMC: 395221. DOI: 10.1002/j.1460-2075.1994.tb06626.x. View